No article text was recorded for this version.
isoform-selective inhibition
Version 1 of 155 papers72 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Novel therapeutic strategies for targeting fatty acid oxidation in cancer
- Blog: Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies
- Blog: A Small Molecule Selectively Targets N-Myc to Suppress Neuroblastoma Cancer Progression
- Blog: Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway
- Blog: PKC regulates αKlotho gene expression in MDCK and NRK-52E cells
- Blog: Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
- Blog: The molecular mechanisms of peptidyl-prolyl cis/trans isomerase Pin1 and its relevance to kidney disease
- Blog: Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy
- Blog: Development of a Cx46 targeting strategy for cancer stem cells
- Blog: Synthesis and biological activities of two camptothecin derivatives against Spodoptera exigua
- Blog: Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer
- Blog: Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase
- Blog: Pharmacological HIF2α inhibition improves VHL disease–associated phenotypes in zebrafish model
- Blog: A bibliometric and visual analysis of Jak1 to explore trends and frontiers
- Blog: Basonuclin-2 promotes fracture repair through NuRD-dependent chromatin remodeling in periosteal stem cells
- Blog: ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
- Blog: Post-translational Modifications of IκBα: The State of the Art
- Blog: TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
- Blog: β-arrestin2 regulates TRAIL-induced HepG2 cell apoptosis via the Src-extracellular signal-regulated signaling pathway
- Blog: An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
- Blog: CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
- Blog: ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
- Blog: Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα
- Blog: Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells
- Blog: KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson’s disease
- Blog: Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells
- Blog: STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT–MET switch and cancer metastasis
- Blog: Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
- Blog: Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development
- Blog: HDAC8-Selective Inhibition by PCI-34051 Attenuates Inflammation and Airway Remodeling in Asthma via miR-381-3p-TGFβ3 axis
- Blog: Pharmacological Effects of a Novel Bradykinin-Related Peptide (RR-18) from the Skin Secretion of the Hejiang Frog (Ordorrana hejiangensis) on Smooth Muscle
- Blog: A combinatorial screening protocol for identifying novel and highly potent dual-target inhibitor of BRD4 and STAT3 for kidney cancer therapy
- Blog: Identification of novel leishmanicidal molecules by virtual and biochemical screenings targeting Leishmania eukaryotic translation initiation factor 4A
- Blog: IOX1 protects from TGF‑β induced fibrosis in LX‑2 cells via the regulation of extracellular matrix protein expression
- Blog: A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib’s Journey from Discovery to Approval and What’s Next in CDK Inhibition in Breast Cancer
- Blog: Identification of the Novel TMEM16A Inhibitor Dehydroandrographolide and Its Anticancer Activity on SW620 Cells
- Blog: Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells
- Blog: Function of serine/arginine-rich splicing factors in hematopoiesis and hematopoietic malignancies
- Blog: Advances in the development of Rho-associated protein kinase (ROCK) inhibitors
- Blog: C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo
- Blog: Characterization of selective and potent PI3Kδ inhibitor (PI3KD-IN-015) for B-Cell malignances
- Blog: Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches
- Blog: VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis
- Blog: ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer’s disease
- Blog: A Phase I Dose-Escalation Study of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Oral Dose of Tigulixostat
- Blog: cAMP Level Modulates Scleral Collagen Remodeling, a Critical Step in the Development of Myopia
- Blog: Effect of the nonsteroidal anti-inflammatory drug 480156-S on hepatic drug-metabolizing activity and pharmacological action of diazepam and pentobarbital in rats.
- Blog: Structure-guided computational insecticide discovery targeting <i>β</i> -N-acetyl-D-hexosaminidase of <i>Ostrinia furnacalis</i>
- Blog: The Role of Translation Initiation Regulation in Tumorigenesis, Progression and Drug Resistance
- Blog: Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
- Blog: Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action
- Blog: Effects of nNOS inhibition on the Escherichia coli and butyrate-producing bacteria in IBS rats with visceral hypersensitivity
- Blog: USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis
- Blog: Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs
- Blog: Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
History & citation
Current · Permanent link
- Isoform Selective Targeting for Precision Enzyme Inhibition merged into this direction (80% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_isoform_selective_inhibition_ab8f0674,
title = {isoform-selective inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/isoform-selective-inhibition/rdr_ab8f0674f2ef4eb7aa0664380bdaa590},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_isoform_selective_inhibition_ab8f0674_v1,
title = {isoform-selective inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/isoform-selective-inhibition/rdr_ab8f0674f2ef4eb7aa0664380bdaa590/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}